Bacterial infections in palliative care: antibiotic and therapeutic limitations

被引:3
作者
Beziaud, Nicolas [1 ]
Pavese, Patricia [2 ]
Barnoud, Didier
Laval, Guillemette [1 ]
机构
[1] CHU Grenoble, Equipe Mobile Soins Palliatifs & Coordinat Soins, F-38043 Grenoble 09, France
[2] CHU Grenoble, Serv Malad Infect & Trop, F-38043 Grenoble, France
来源
PRESSE MEDICALE | 2009年 / 38卷 / 06期
关键词
ADVANCED CANCER-PATIENTS; RECEIVING HOSPICE CARE; NEOPLASTIC FEVER; HYPODERMOCLYSIS; MANAGEMENT; FREQUENCY; PAIN;
D O I
10.1016/j.lpm.2008.10.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The benefits of antibiotics treatments are not obvious at the end of life except for the symptomatic urinary infections. The numerous antibiotics prescribed raise economic and ecological problems in terms of bacterial resistances development and also in terms of quality of life. The control of symptoms has to be the main indication to prescribe antibiotics at the end of life. It is the general state, the prognostic of the patient, his wishes and those of his family, and his symptoms controlled or not, that direct the decision to prescribe on antibiotic. Physicians must consider the objective of antibiotic treatment, the risk of side effects and the constraints related to this treatment before prescribing it for terminally ill people. They hove to respect the bioethical principles, primarily the principles of beneficence, non-maleficience, and the respect to autonomy of the patient. In the event of decision of on antibiotic treatment at a patient at the end of the lifetime, the choice of this one must answer obviously the same requirements as in the other medical situations, within the framework of comprehensive and rigorous process.
引用
收藏
页码:935 / 944
页数:10
相关论文
共 31 条
[1]   Treatment of the dying in the acute care hospital - Advanced dementia and metastatic cancer [J].
Ahronheim, JC ;
Morrison, RS ;
Baskin, SA ;
Morris, J ;
Meier, DE .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (18) :2094-2100
[2]  
*AMR C GROUP ET RE, 1997, 17 RICAI
[3]  
AUBRY R, 2008, REV PRATICIEN, V22, P137
[4]  
Beauchamp TL., 2009, PRINCIPLES BIOMEDICA
[5]  
BRUERA E, 1986, CANCER TREAT REP, V70, P691
[6]  
*CCNE, 2000, N6327 CCNE
[7]   Single-dose pharmacokinetics of ampicillin and tobramycin administered by hypodermoclysis in young and older healthy volunteers [J].
Champoux, N ;
DuSouich, P ;
Ravaoarinoro, M ;
Phaneuf, D ;
Latour, J ;
Cusson, JR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (03) :325-331
[8]  
*COM EXP OMS, 1990, 804 OMS
[9]  
Daout C., 2007, ETHIQUE SANTE, V4, P78
[10]   Hypodermoclysis:: benefits and indications in geriatrics [J].
Dardaine-Giraud, V ;
Lamandé, M ;
Constans, T .
REVUE DE MEDECINE INTERNE, 2005, 26 (08) :643-650